Micropillar Optical Cell Typing for Rapid Drug Resistance Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for evaluating cell drug resistance are time-consuming, costly, and lack specificity, making it difficult to identify and screen for drug-resistant cells, especially in urgent medical situations, and traditional systems cause damage to normal cells during cancer treatment.
Innovation Solution
A cell characterization system that measures cell mechanical force and stiffness to identify drug resistance levels using a micropillar array with a light-reflective layer, allowing for real-time, high-throughput, and low-cost identification of drug-resistant cells through optical signal detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional animal testing or cell culture methods are used to evaluate cell drug resistance, then comprehensive drug resistance evaluation can be achieved, but the process becomes time-consuming and costly
Solution Approach 1:
The patent replaces traditional mechanical and biochemical drug resistance evaluation methods with an optical measurement system. By using a light source to illuminate cells and detecting optical signal changes, the system achieves rapid drug resistance assessment without time-consuming animal testing or cell culture processes, directly resolving the contradiction between evaluation accuracy and time consumption
Solution Approach 2:
The patent changes the measurement parameter from biochemical responses to optical properties. By measuring changes in optical signals (such as light absorption, reflection, or scattering) of cells under drug treatment, the system enables rapid quantification of drug resistance levels, significantly reducing evaluation time while maintaining measurement precision
2Reliability
If traditional cytotoxic drugs are used to treat cancer, then tumor cells can be effectively killed, but normal cells suffer severe damage
Solution Approach 1:
The patent segments the cell population into drug-resistant tumor cells and drug-sensitive normal cells based on their differential responses to drug treatment. By identifying and isolating drug-resistant cells through optical screening, the system enables targeted therapy that spares normal cells from cytotoxic damage while effectively treating tumor cells
Solution Approach 2:
The patent performs preliminary identification and classification of drug-resistant cells before administering cytotoxic therapy. By pre-screening cells using the optical system to determine their drug resistance profile, the treatment plan can be optimized to maximize tumor cell killing while minimizing damage to normal cells, achieving effective tumor treatment with reduced side effects
3Productivity
If conventional drug screening methods are used, then drug resistance can be evaluated, but the process lacks specificity and sensitivity
Solution Approach 1:
The patent replaces conventional biochemical and morphological cell characterization methods with optical measurement techniques. By detecting subtle changes in optical properties of individual cells, the system achieves both high-throughput screening capability and high measurement precision, simultaneously improving productivity and characterization accuracy
Solution Approach 2:
The patent utilizes changes in optical properties (such as light absorption, scattering, or fluorescence) of cells as they respond to drug treatment. By monitoring these optical signal changes, the system achieves specific and sensitive detection of drug resistance levels, enabling accurate cell characterization with high throughput
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables accurate differentiation of drug-resistant and non-drug-resistant cells with over 98% accuracy, reducing operational complexity and cost while providing real-time monitoring and minimizing phototoxic effects, suitable for drug screening and precision medicine applications.
Implementation Method 1
A cell characterization system that measures cell mechanical force and stiffness to identify drug resistance levels using a micropillar array with a light-reflective layer, allowing for real-time, high-throughput, and low-cost identification of drug-resistant cells through optical signal detection
Data Source
Figure 1~3
Figure 4~6b
Figure 7a~9
AI summary
This application relates to the field of biotechnology, and more particularly to a system, method, and application for cell identification, classification, and characterization based on drug sensitivity. The cell characterization system comprises a cell mechanical force detection device. The cell mechanical force detection device includes a base and, disposed on the base, a micropillar array composed of at least one micropillar that can deform under the cellular mechanical force exerted by cells or multicellular aggregates. The tops and/or upper surfaces of the micropillars are provided with a light-reflective layer. The cells or multicellular aggregates exhibit a corresponding degree of drug sensitivity to specific drugs. The cell identification and classification system includes an information acquisition unit, a pre-processing unit, a learning unit, and a recognition unit. This application distinguishes between cells or multicellular aggregates with different degrees of drug resistance by using cellular mechanical forces. This identification can be completed in a short period, thereby enabling the screening of precision medicines with an accuracy rate of over 98%.